13F Filings History of RENAISSANCE TECHNOLOGIES LLC

13F snapshot Latest parsed holdings, value, and filing-period context. 2 signals
Form 13F summary
  • RENAISSANCE TECHNOLOGIES LLC Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
  • Form 13F is generally due within 45 days after each calendar quarter ends.
  • RENAISSANCE TECHNOLOGIES LLC reported 3184 equity holdings with a total reported market value of $64,461,244,358 for Q4 2025. Top reported holdings included PALANTIR TECHNOLOGIES INC, UNITED THERAPEUTICS CORP DEL, MICRON TECHNOLOGY INC, KINROSS GOLD CORP, and VERISIGN INC.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
Tiffany Michel - Chief Compliance Officer
Manager location
New York, NY

Follow Filing Activity

Follow RENAISSANCE TECHNOLOGIES LLC with Pro and return when a new 13F portfolio filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Holdings Value

Form 13F evidence

Quarterly portfolio filings

SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.

Latest quarter
Q4 2025
Latest value
$64,461,244,358
Quarter delta
-$11,291,938,158
Accepted
12 Feb 2026, 14:24
Rows shown
1-9 of 9
Quarter Holdings SEC-reported value Bought Sold Net Top Holdings Form Type Accepted by SEC
Q4 2025 3,184 $64,461,244,358 +$14,563,754,901 -$25,036,262,194 -$10,472,507,293 PALANTIR TECHNOLOGIES INC, UNITED THERAPEUTICS CORP DEL, MICRON TECHNOLOGY INC, KINROSS GOLD CORP, VERISIGN INC 13F-HR 12 Feb 2026, 14:24
Q3 2025 3,456 $75,753,182,516 +$15,349,487,698 -$21,318,933,034 -$5,969,445,336 PALANTIR TECHNOLOGIES INC, NVIDIA CORPORATION, ROBLOX CORP, UNITED THERAPEUTICS CORP DEL, VERISIGN INC 13F-HR 13 Nov 2025, 14:18
Q2 2025 3,522 $75,171,481,593 +$19,917,920,861 -$17,804,238,448 +$2,113,682,413 PALANTIR TECHNOLOGIES INC, NVIDIA CORPORATION, ROBINHOOD MKTS INC, VERISIGN INC, NETFLIX INC 13F-HR 13 Aug 2025, 15:37
Q1 2025 3,406 $66,072,250,548 +$15,160,099,710 -$15,512,487,564 -$352,387,854 PALANTIR TECHNOLOGIES INC, VERISIGN INC, CORCEPT THERAPEUTICS INC, ROBINHOOD MKTS INC, SPROUTS FMRS MKT INC 13F-HR 14 May 2025, 15:11
Q4 2024 3,533 $67,553,776,837 +$13,350,853,342 -$14,233,634,864 -$882,781,522 PALANTIR TECHNOLOGIES INC, UNITED THERAPEUTICS CORP DEL, NOVO-NORDISK A S, APPLE INC, VERISIGN INC 13F-HR 13 Feb 2025, 09:38
Q3 2024 3,484 $66,497,322,888 +$15,607,650,124 -$12,080,968,113 +$3,526,682,011 PALANTIR TECHNOLOGIES INC, NOVO-NORDISK A S, UNITED THERAPEUTICS CORP DEL, APPLE INC, VERTEX PHARMACEUTICALS INC 13F-HR 13 Nov 2024, 14:21
Q2 2024 3,443 $58,958,710,563 +$12,009,356,868 -$10,545,945,256 +$1,463,411,612 NOVO-NORDISK A S, PALANTIR TECHNOLOGIES INC, NVIDIA CORPORATION, VERTEX PHARMACEUTICALS INC, UNITED THERAPEUTICS CORP DEL 13F-HR 09 Aug 2024, 16:10
Q1 2024 3,657 $63,623,687 +$12,072,656 -$17,691,527 -$5,618,871 NOVO-NORDISK A S, PALANTIR TECHNOLOGIES INC, META PLATFORMS INC, AIRBNB INC, AMAZON COM INC 13F-HR 13 May 2024, 16:35
Q4 2023 3,682 $64,606,784 $0 $0 $0 NOVO-NORDISK A S, UBER TECHNOLOGIES INC, NVIDIA CORPORATION, PALANTIR TECHNOLOGIES INC, META PLATFORMS INC 13F-HR 13 Feb 2024, 11:29
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .